valve

acceso

TAVR: Should Transradial Approach be the Second Access Site?

Courtesy of Dr. Carlos Fava. One of the major challenges we interventional cardiologists still face is access management. Reduced device diameter and improved transcatheter closure, together with increased operator experience, have significantly reduced vascular complications. However, we shouldn’t lose sight of the secondary access, usually transfemoral, generally used in case of primary access site related<a href="https://solaci.org/en/2020/03/04/tavr-should-transradial-approach-be-the-second-access-site/" title="Read more" >...</a>

All You Need to Know on the Ecuador Sessions 2020

All You Need to Know on the Ecuador Sessions 2020

After 3 years, SOLACI returns to Ecuador -this time to the beautiful city of Manta- to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our<a href="https://solaci.org/en/2020/01/21/all-you-need-to-know-on-the-ecuador-sessions-2020/" title="Read more" >...</a>

Cirugía para mejorar la sobrevida en insuficiencia tricuspidea aislada

PASCAL in Tricuspid Regurgitation with Encouraging Results

Courtesy of Dr. Carlos Fava. Tricuspid regurgitation (TR) is associated with higher mortality and morbidity, and it most frequently has a functional cause. Furthermore, it has been proven that tricuspid surgery has mortality rates between 8% and 20%. On the other hand, it has been verified that, in the case of left-sided disease affecting the<a href="https://solaci.org/en/2020/01/21/pascal-in-tricuspid-regurgitation-with-encouraging-results/" title="Read more" >...</a>

The Most Read Scientific Articles of December in Solaci.org

The Most Read Articles of December in solaci.org

1- Consensus on How to Conduct Follow-Up in Peripheral Vascular Disease Peripheral vascular disease involves multiple areas and, therefore, can have very different presentations (from complete lack of symptoms to disabling symptoms). Depending on clinical presentation, general condition, anatomical localization, and lesion extension, revascularization can be indicated alongside optimal medical treatment. Read also HERE 2-<a href="https://solaci.org/en/2020/01/06/the-most-read-articles-of-december-in-solaci-org/" title="Read more" >...</a>

Luz roja para el TAVI en pacientes de bajo riesgo

Unilateral Vascular Access in TAVR: Our Main Procedure, Increasingly Minimalist

There has been a significant decline in vascular complications in the last few years due to improvements in device profiles and operator experience on transcatheter aortic valve replacement (TAVR). Unilateral vascular access for transfemoral TAVR is as safe as bilateral access and it could be more comfortable for patients according to this study recently published<a href="https://solaci.org/en/2019/12/08/unilateral-vascular-access-in-tavr-our-main-procedure-increasingly-minimalist/" title="Read more" >...</a>

Agreement between SOLACI and the Journal of Structural Heart Disease

It is with great pleasure that SOLACI announces an agreement with the Journal of Structural Heart Disease. From now on, all readers, users and members of SOLACI will be able to access the contents of this prestigious publication from our website. Click on the section &#8220;Publications&#8221;&gt; &#8220;Other Magazines&#8221; of our website, and there you can<a href="https://solaci.org/en/2019/12/06/agreement-between-solaci-and-the-journal-of-structural-heart-disease/" title="Read more" >...</a>

mas-leido-noviembre-eng

The Most Read Articles of November at Solaci.org

1- AHA 2019 | ISCHEMIA: The Invasive Approach (PCI or Surgery) Results Similar to Optimal Medical Treatment After a several year follow up, the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) has shown that an invasive approach in addition to optimal medical treatment (OMT) does not offer benefits when it<a href="https://solaci.org/en/2019/12/02/the-most-read-articles-of-november-at-solaci-org/" title="Read more" >...</a>

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

Pre-TAVR Revascularization: Angiographic or Physiological?

In patients undergoing transcatheter aortic valve replacement (TAVR), fractional flow reserve (FFR) guided revascularization is associated with favorable results compared against the traditional angiography guided revascularization.&nbsp; Given the complete lack of randomized studies, this observational study is the best we have to decide how to guide revascularization in patients with symptomatic severe aortic stenosis undergoing<a href="https://solaci.org/en/2019/11/28/pre-tavr-revascularization-angiographic-or-physiological/" title="Read more" >...</a>

AHA 2019 | Sapien vs Evolut: A Head-to-Head Study Seems Mandatory

Two French registries have carried out a propensity matched comparison which suggest differences between balloon-expandable valves (BEV) and self-expandable valves (SEV) in hard end points such as mortality.&nbsp; The only FDA approved commercially available transcatheter heart valves in the US are the BE Sapien 3 (Edwards Lifesciences) and the SE CoreValve Evolut PRO (Medtronic). Both<a href="https://solaci.org/en/2019/11/27/aha-2019-sapien-vs-evolut-a-head-to-head-study-seems-mandatory/" title="Read more" >...</a>

Treat Stroke to Target: terapia agresiva con estatinas post stroke

AHA 2019 | Treat Stroke to Target: Post-Stroke Aggressive Therapy with Statins

Indicating statins to reach more aggressive LDL goals in patients that have suffered transient ischemic attack or ischemic stroke driven by atherosclerosis significantly reduces major cardiovascular events according to this study presented in the AHA 2019 scientific sessions simultaneously published in NEJM. The study was prematurely ended because of lack of funding, but its outcomes<a href="https://solaci.org/en/2019/11/26/aha-2019-treat-stroke-to-target-post-stroke-aggressive-therapy-with-statins/" title="Read more" >...</a>

Top